The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $136.65

Today's change+0.53 +0.39%
Updated February 27 3:56 PM EST. Delayed by at least 15 minutes.
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $136.65

Today's change+0.53 +0.39%
Updated February 27 3:56 PM EST. Delayed by at least 15 minutes.

Jazz Pharmaceuticals PLC up (U.S.)$0.53

Jazz Pharmaceuticals PLC closed up Monday by (U.S.)$0.53 or 0.39% to (U.S.)$136.65. Shares have lost 0.40% over the last five days, but have gained 25.33% over the last year to date. This security has underperformed the S&P 500 by 12.29% during the last year.

Key company metrics

  • Open(U.S.) $135.45
  • Previous close(U.S.) $136.11
  • High(U.S.) $137.89
  • Low(U.S.) $134.96
  • Bid / Ask(U.S.) $136.64 / (U.S.) $136.77
  • YTD % change+25.33%
  • Volume588,935
  • Average volume (10-day)528,453
  • Average volume (1-month)632,687
  • Average volume (3-month)640,475
  • 52-week range(U.S.) $95.80 to (U.S.) $160.00
  • Beta1.22
  • Trailing P/E23.91×
  • P/E 1 year forward13.65×
  • Forward PEG0.78×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.72
Updated February 27 3:56 PM EST. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue374381336341
Total other revenue--------
Total revenue374381336341
Gross profit350357313317
Total cost of revenue24242324
Total operating expense239212215234
Selling / general / administrative124123129124
Research & development63394029
Depreciation / amortization26272324
Interest expense (income), net operating--------
Unusual expense (income)10--33
Other operating expenses, total--------
Operating income136169121107
Interest income (expense), net non-operating-18-12-12-12
Gain (loss) on sale of assets--------
Other--------
Income before tax11615710897
Income after tax871117483
Income tax, total29453414
Net income871117483
Total adjustments to net income--------
Net income before extra. items871117483
Minority interest00--0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items871117483
Inc. avail. to common incl. extra. items871117483
Diluted net income871117483
Dilution adjustment--00--
Diluted weighted average shares62626263
Diluted EPS excluding extraordinary itemsvalue per share1.411.801.191.32
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.421.801.161.57